M Craig Miller

发表

Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow‐up after radical prostatectomy

Robert W Veltri, Alan W Partin, A. Partin, 2010, The Prostate.

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.

Steven J Skates, Richard G. Moore, R. Bast, 2009, Gynecologic oncology.

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

Robert W Veltri, Alan W Partin, Danil V Makarov, 2008, The Prostate.

Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Alison Stopeck, Massimo Cristofanilli, Leon W M M Terstappen, 2004, The New England journal of medicine.

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.

Steven J Skates, Richard G. Moore, R. Bast, 2010, American journal of obstetrics and gynecology.

Quantitative biopsy pathology for the prediction of pathologically organ‐confined prostate carcinoma

Hartwig Huland, Markus Graefen, Robert W Veltri, 2003, Cancer.

Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.

Robert W Veltri, Alan W Partin, A. Partin, 2002, The Journal of urology.

Prediction of Prostate-Specific Antigen Recurrence in Men with Long-term Follow-up Postprostatectomy Using Quantitative Nuclear Morphometry

Robert W Veltri, Alan W Partin, Danil V Makarov, 2008, Cancer Epidemiology Biomarkers & Prevention.

Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study.

Robert W Veltri, M. Miller, R. Veltri, 2003, The Journal of urology.

Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stage.

Robert W Veltri, Alan W Partin, A. Partin, 2002, Clinical chemistry.

Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy

Robert W Veltri, Alan W Partin, A. Partin, 2003, Cancer.

Statistical considerations for enumeration of circulating tumor cells

Leon W M M Terstappen, M. Miller, L. Terstappen, 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

Thorsten Verch, Richard G. Moore, R. Bast, 2008, Gynecologic oncology.

PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis

Mikhail Gorbounov, Neil M Carleton, Robert W Veltri, 2018, The Prostate.

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Michael Morse, Nicholas Iannotti, Neal J Meropol, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

Alison Stopeck, Massimo Cristofanilli, Leon W M M Terstappen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating tumor cells predict survival in patients with metastatic prostate cancer.

W. J. Allard, M. Miller, L. Terstappen, 2005, Urology.